Skip to main content

Research News

  • New discovery finds gene converts insulin-producing cells into blood-sugar boosters

    Scientists at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S., and a leading research center for diabetes and other life-threatening illnesses, have uncovered a gene called SMOC1 that plays a surprising role in the development of type 2 diabetes (T2D) by converting pancreatic cells that normally produce insulin into those that increase blood sugar.
  • Tiny Particles and Vinegar May Help Kill Superbugs, Say Scientists
    Tiny Particles and Vinegar May Help Kill Superbugs, Say Scientists
    A new study has found that a simple kitchen ingredient — vinegar — can become a powerful germ killer when mixed with special microscopic particles. Scientists have discovered that this new combination could help fight dangerous bacteria that no longer respond to regular antibiotics.
  • New Drug Candidate Blocks Lung Cancer Growth Without Harming Healthy Cells
    New Drug Candidate Blocks Lung Cancer Growth Without Harming Healthy Cells

    Lung cancer remains one of the deadliest cancers worldwide, with survival rates stubbornly low despite advances in surgery, chemotherapy, and immunotherapy. But a new discovery may change the way doctors approach treatment.

  • Systemically injectable therapy could prevent heart failure after a heart attack
    Systemically injectable therapy could prevent heart failure after a heart attack
    Scientists at Northwestern University and University of California San Diego have developed a new, potent injectable therapy that can protect the heart from damage after a heart attack.
  • Microscopic pores in brain cells may be a key to Parkinson’s
    Microscopic pores in brain cells may be a key to Parkinson’s
    A toxic protein forms dynamic pores in the membranes of brain cells – and that may be the key to understanding how Parkinson’s disease develops. This is the conclusion of a new study from Aarhus University, where researchers have developed an advanced method to track molecular attacks in real time.
  • FDA recommends more MRI monitoring for patients with Alzheimer’s disease taking Leqembi (lecanemab)
    FDA recommends more MRI monitoring for patients with Alzheimer’s disease taking Leqembi (lecanemab)

    The U.S. Food and Drug Administration (FDA) is recommending an additional, earlier magnetic resonance imaging (MRI) monitoring prior to the 3rd infusion for patients with Alzheimer’s disease taking Leqembi (lecanemab). The earlier monitoring can identify individuals with amyloid-related imaging abnormalities with edema (ARIA-E), which is characterized by brain swelling or fluid buildup. ARIA-E is usually asymptomatic, although serious and life-threatening events, including seizure and status epilepticus, can occur and there have been deaths.

  • Computational neurogenomics revolution unlocks personalized treatments for brain disorders worldwide
    Computational neurogenomics revolution unlocks personalized treatments for brain disorders worldwide
    In a compelling interview with Genomic Press, published today in Genomic Psychiatry, Dr. Miguel E. Rentería reveals how his journey from Mexico to becoming one of Australias most influential neuroscientists exemplifies the transformative power of curiosity, determination, and global scientific collaboration.
  • Breakthrough in indole chemistry could accelerate drug development
    Breakthrough in indole chemistry could accelerate drug development
    Indole, a molecule made up of a six-membered benzene ring fused to a five-membered ring containing nitrogen, forms the core structure of many biologically active compounds.
  • Midkine protein plays a preventive role against Alzheimer’s disease
    Midkine protein plays a preventive role against Alzheimer’s disease
    Scientists at St. Jude Childrens Research Hospital demonstrated for the first time that the protein midkine plays a preventative role against Alzheimers disease.
  • One Universal Antiviral to Rule Them All?
    One Universal Antiviral to Rule Them All?
    For a few dozen people in the world, the downside of living with a rare immune condition comes with a surprising superpower—the ability to fight off all viruses. Columbia immunologist Dusan Bogunovic discovered the individuals’ antiviral powers about 15 years ago, soon after he identified the genetic mutation that causes the condition.
Subscribe to Research News